MARY KAY FOUNDATION PRIMER- avobenzone, homosalate, octisalate, octocrylene gel 
Mary Kay Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Mary Kay Foundation Primer SPF 15

Drug Facts

Active Ingredients

Avobenzone 2.5%

Homosalate 9%

Octisalate 5%

Octocrylene 3%

Purpose

Sunscreen

Uses

Warnings

For external use only

Do not use

on damaged or broken skin

When using this product

keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor

if rash occurs

Keep out of reach of children.

If product is swallowed, get medical help or contact a Poison Control Center right away.

Directions

Inactive ingredients

isododecane, dimethicone/bis-isobutyl PPG-20 crosspolymer, polysilicone-11, vp/hexadecene copolymer, silica, C12-15 alkyl benzoate, polyester-7, neopentyl glycol diheptanoate, tribehenin, dipropylene glycol dibenzoate, PPG-15 stearyl ether benzoate

Other information

protect this product from excessive heat and direct sun

Questions or comments?

Call toll free 1-800-627-9529

Principal Display Panel - 29 mL carton

Mary Kay

foundation primer

sunscreen

broad spectrum

spf 15

1 FL. OZ. / 29 mL

image of foundation primer carton

MARY KAY FOUNDATION PRIMER 
avobenzone, homosalate, octisalate, octocrylene gel
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:51531-0850
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX) AVOBENZONE2.5 g  in 100 mL
HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE9 g  in 100 mL
OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE5 g  in 100 mL
OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM) OCTOCRYLENE3 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE) (UNII: 9E4CO0W6C5)  
ISODODECANE (UNII: A8289P68Y2)  
DIMETHICONE/BIS-ISOBUTYL PPG-20 CROSSPOLYMER (UNII: O4I3UFO6ZF)  
VINYLPYRROLIDONE/HEXADECENE COPOLYMER (UNII: KFR5QEN0N9)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
ALKYL (C12-15) BENZOATE (UNII: A9EJ3J61HQ)  
POLYESTER-7 (UNII: 0841698D2F)  
NEOPENTYL GLYCOL DIHEPTANOATE (UNII: 5LKW3C543X)  
TRIBEHENIN (UNII: 8OC9U7TQZ0)  
DIPROPYLENE GLYCOL DIBENZOATE (UNII: 6OA5ZDY41O)  
PPG-15 STEARYL ETHER BENZOATE (UNII: 80D2J6361M)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:51531-0850-11 in 1 CARTON03/01/2012
129 mL in 1 TUBE; Type 0: Not a Combination Product
2NDC:51531-0850-00.5 mL in 1 PACKET; Type 0: Not a Combination Product03/01/2012
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalM02003/01/2012
Labeler - Mary Kay Inc. (049994452)
Establishment
NameAddressID/FEIBusiness Operations
Mary Kay Inc.103978839manufacture(51531-0850)

Revised: 10/2022
Document Id: eab4a7a6-b3f2-0e2f-e053-2a95a90a4bdf
Set id: 59d25b44-1adb-4790-8ce6-2d847a06b8b3
Version: 6
Effective Time: 20221010
 
Mary Kay Inc.